stocktools
Dilution profile // every instrument, one screen, from SEC filings

Propanc Biopharma, Inc. (PPCB)

CIK 1517681 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed sub-ratings (cash need)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
MEDIUM$9.0M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
LOWwarrants = 0% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW-57% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
HIGH~0.2 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-11-122026-09-23

Latest: 6.3M shares as of Sep 23, 2026 (10-K).

⊙
EVIDENCE — filed/published fact
SourceSEC XBRL, cover-page share count
Fielddei:EntityCommonStockSharesOutstanding
As of2026-09-23
HowThe newest cover-page count as filed, whatever its age. The float checker applies a 200-day freshness rule and sets this beside the balance-sheet count.
Open the source document →
Share count fell from 789.9M to 15,372 between Nov 14, 2024 and Feb 12, 2025, a pattern consistent with a reverse split (roughly 1-for-51386); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 12,000 underlying shares, as reported Jun 30, 2018 (10-K).

Reported exercise price: $2 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $104,313 as of Mar 31, 2026.

Rough fully diluted estimate: 6.3M = 6.3M O/S + 12,000 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

NotePrincipalCarryingConv. priceRateIf converted
Convertible Debt One$54,850—not tagged——

Notes exactly as the company dimensioned them in its 10-K filed Sep 25, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding6.3MSep 23, 2026
+ Warrants (aggregate, as tagged) (if exercised)12,000Jun 30, 2018
+ Convertible debt (aggregate carrying / conversion price) (if fully converted)891.778Jun 30, 2026
Fully diluted estimate6.3M+0.2% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $9.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-1Oct 5, 2026$3.3M registeredfiling →
S-1Jul 17, 2026$4.1M registeredfiling →
S-1Apr 10, 2026$1.7M registeredfiling →

Last 12 months: 1 executed · 6 registered.

REGISTEREDOct 5, 2026S-1 registration — capacity to sell shares, not a sale yetS-1 →
EFFECTIVEJul 27, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJul 17, 2026S-1 registration — capacity to sell shares, not a sale yetS-1 →
EFFECTIVEApr 20, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDApr 10, 2026S-1 registration — capacity to sell shares, not a sale yetS-1 →
UPDATEMar 6, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEFeb 24, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDFeb 19, 2026S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDFeb 2, 2026S-1 registration — capacity to sell shares, not a sale yetS-1 →
UPDATEJan 30, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEJan 9, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDDec 30, 2025S-1 registration — capacity to sell shares, not a sale yetS-1 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full PPCB workspace